TSH suppression therapy from an individualized perspective: from mechanism to clinical decision-making - Top-Institutions - MDSpire

TSH suppression therapy from an individualized perspective: from mechanism to clinical decision-making

  • By

  • Zhaoqing Li

  • Tengfei Wang

  • Jia Liu

  • July 7, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Endocrinology
    • Oncology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Oncology

Original Source(s)

TSH suppression therapy from an individualized perspective: from mechanism to clinical decision-making

  • by Zhaoqing Li, Tengfei Wang, Jia Liu

  • July 7, 2026

Related Content

Histopathological biomarkers of immunotherapy outcome in advanced colorectal cancer: a multicentre retrospective study

Prognostic significance of inflammation-based markers in nasopharyngeal carcinoma: a systematic review and meta-analysis

Study on the application of thermo-optical surface monitoring + X-ray guidance system in DIBH for breast cancer